Photo of George Jenkins

George Jenkins

George Jenkins sits in Covington’s Band 1 ranked Life Sciences Transactions team, specializing in advising life sciences and digital health clients on complex, strategic commercial agreements. In particular, he advises clients on structuring, negotiating and drafting their collaborations, joint ventures, IP licensing, co-development arrangements, and agreements for the manufacture, distribution, and supply of goods. George also regularly works closely with the firm's Corporate Practice Group on product divestments, asset transfers, and related transitional agreements.

George has experience in advising on regulatory matters in the life sciences sector, including advising on regulatory and licensing requirements to enable clients to develop and commercialize their products in the EU. He understands the regulatory environment affecting the life sciences industry and is able to assist clients in setting their commercial arrangements and transactions in their wider regulatory context.

George has also spent time in the in-house legal teams of a number of clients, including at the headquarters of a global pharmaceutical company.

Tune into this episode of Covington’s Life Sciences Audiocast, where Winsome Cheung and George Jenkins discuss the key trends in Life Sciences Transactions for 2024. The speakers discuss the outlook for deal-making in Life Sciences and predictions for deal trends, including in relation to nuclear medicine, GLP-1, antibody-drug conjugates and other modalities. The speakers also